Goodwill of Edwards Lifesciences Corp from 30 Jun 2010 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
Summary
Edwards Lifesciences Corp quarterly Goodwill in USD history and change rate from 30 Jun 2010 to 30 Sep 2025.
  • Edwards Lifesciences Corp Goodwill for the quarter ending 30 Sep 2025 was $1,768,500,000, a 10% increase year-over-year.
Source SEC data
View on sec.gov
Goodwill, Quarterly (USD)
Goodwill, YoY Quarterly Change (%)

Edwards Lifesciences Corp Quarterly Goodwill (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $1,768,500,000 +$163,200,000 +10% 30 Sep 2025 10-Q 05 Nov 2025 2025 Q3
Q2 2025 $1,776,700,000 +$625,700,000 +54% 30 Jun 2025 10-Q 06 Aug 2025 2025 Q2
Q1 2025 $1,778,700,000 +$525,900,000 +42% 31 Mar 2025 10-Q 06 May 2025 2025 Q1
Q4 2024 $1,776,700,000 +$631,600,000 +55% 31 Dec 2024 10-Q 05 Nov 2025 2025 Q3
Q3 2024 $1,605,300,000 +$307,900,000 +24% 30 Sep 2024 10-Q 06 Nov 2024 2024 Q3
Q2 2024 $1,151,000,000 -$148,500,000 -11% 30 Jun 2024 10-Q 31 Jul 2024 2024 Q2
Q1 2024 $1,252,800,000 -$55,600,000 -4.2% 31 Mar 2024 10-Q 29 Apr 2024 2024 Q1
Q4 2023 $1,145,100,000 +$80,300,000 +7.5% 31 Dec 2023 10-K 28 Feb 2025 2024 FY
Q3 2023 $1,297,400,000 +$138,700,000 +12% 30 Sep 2023 10-Q 27 Oct 2023 2023 Q3
Q2 2023 $1,299,500,000 +$135,400,000 +12% 30 Jun 2023 10-Q 28 Jul 2023 2023 Q2
Q1 2023 $1,308,400,000 +$142,100,000 +12% 31 Mar 2023 10-Q 28 Apr 2023 2023 Q1
Q4 2022 $1,064,800,000 -$103,100,000 -8.8% 31 Dec 2022 10-K 28 Feb 2025 2024 FY
Q3 2022 $1,158,700,000 -$11,700,000 -1% 30 Sep 2022 10-Q 28 Oct 2022 2022 Q3
Q2 2022 $1,164,100,000 -$7,700,000 -0.66% 30 Jun 2022 10-Q 29 Jul 2022 2022 Q2
Q1 2022 $1,166,300,000 -$4,500,000 -0.38% 31 Mar 2022 10-Q 28 Apr 2022 2022 Q1
Q4 2021 $1,167,900,000 -$5,300,000 -0.45% 31 Dec 2021 10-K 12 Feb 2024 2023 FY
Q3 2021 $1,170,400,000 +$400,000 +0.03% 30 Sep 2021 10-Q 29 Oct 2021 2021 Q3
Q2 2021 $1,171,800,000 +$4,100,000 +0.35% 30 Jun 2021 10-Q 30 Jul 2021 2021 Q2
Q1 2021 $1,170,800,000 +$4,600,000 +0.39% 31 Mar 2021 10-Q 28 Apr 2021 2021 Q1
Q4 2020 $1,173,200,000 +$5,500,000 +0.47% 31 Dec 2020 10-K 13 Feb 2023 2022 FY
Q3 2020 $1,170,000,000 +$13,400,000 +1.2% 30 Sep 2020 10-Q 26 Oct 2020 2020 Q3
Q2 2020 $1,167,700,000 -$6,200,000 -0.53% 30 Jun 2020 10-Q 27 Jul 2020 2020 Q2
Q1 2020 $1,166,200,000 +$62,800,000 +5.7% 31 Mar 2020 10-Q 28 Apr 2020 2020 Q1
Q4 2019 $1,167,700,000 +$55,500,000 +5% 31 Dec 2019 10-K 14 Feb 2022 2021 FY
Q3 2019 $1,156,600,000 +$34,300,000 +3.1% 30 Sep 2019 10-Q 25 Oct 2019 2019 Q3
Q2 2019 $1,173,900,000 +$55,300,000 +4.9% 30 Jun 2019 10-Q 26 Jul 2019 2019 Q2
Q1 2019 $1,103,400,000 -$41,400,000 -3.6% 31 Mar 2019 10-Q 26 Apr 2019 2019 Q1
Q4 2018 $1,112,200,000 -$14,300,000 -1.3% 31 Dec 2018 10-K 12 Feb 2021 2020 FY
Q3 2018 $1,122,300,000 +$141,800,000 +14% 30 Sep 2018 10-Q 26 Oct 2018 2018 Q3
Q2 2018 $1,118,600,000 +$153,500,000 +16% 30 Jun 2018 10-Q 27 Jul 2018 2018 Q2
Q1 2018 $1,144,800,000 +$199,600,000 +21% 31 Mar 2018 10-Q 27 Apr 2018 2018 Q1
Q4 2017 $1,126,500,000 +$500,400,000 +80% 31 Dec 2017 10-K 14 Feb 2020 2019 FY
Q3 2017 $980,500,000 +$350,500,000 +56% 30 Sep 2017 10-Q 27 Oct 2017 2017 Q3
Q2 2017 $965,100,000 +$335,700,000 +53% 30 Jun 2017 10-Q 28 Jul 2017 2017 Q2
Q1 2017 $945,200,000 +$314,300,000 +50% 31 Mar 2017 10-Q 28 Apr 2017 2017 Q1
Q4 2016 $626,100,000 -$2,200,000 -0.35% 31 Dec 2016 10-K 15 Feb 2019 2018 FY
Q3 2016 $630,000,000 +$8,800,000 +1.4% 30 Sep 2016 10-Q 28 Oct 2016 2016 Q3
Q2 2016 $629,400,000 +$258,500,000 +70% 30 Jun 2016 10-Q 29 Jul 2016 2016 Q2
Q1 2016 $630,900,000 +$262,500,000 +71% 31 Mar 2016 10-Q 29 Apr 2016 2016 Q1
Q4 2015 $628,300,000 +$252,300,000 +67% 31 Dec 2015 10-K 16 Feb 2018 2017 FY
Q3 2015 $621,200,000 +$242,200,000 +64% 30 Sep 2015 10-Q 29 Oct 2015 2015 Q3
Q2 2015 $370,900,000 -$13,400,000 -3.5% 30 Jun 2015 10-Q 29 Jul 2015 2015 Q2
Q1 2015 $368,400,000 -$17,000,000 -4.4% 31 Mar 2015 10-Q 29 Apr 2015 2015 Q1
Q4 2014 $376,000,000 -$9,400,000 -2.4% 31 Dec 2014 10-K 17 Feb 2017 2016 FY
Q3 2014 $379,000,000 -$4,800,000 -1.3% 30 Sep 2014 10-Q 31 Oct 2014 2014 Q3
Q2 2014 $384,300,000 +$2,800,000 +0.73% 30 Jun 2014 10-Q 04 Aug 2014 2014 Q2
Q1 2014 $385,400,000 +$5,200,000 +1.4% 31 Mar 2014 10-Q 02 May 2014 2014 Q1
Q4 2013 $385,400,000 +$700,000 +0.18% 31 Dec 2013 10-K 19 Feb 2016 2015 FY
Q3 2013 $383,800,000 +$34,000,000 +9.7% 30 Sep 2013 10-Q 07 Nov 2013 2013 Q3
Q2 2013 $381,500,000 +$31,700,000 +9.1% 30 Jun 2013 10-Q 06 Aug 2013 2013 Q2
Q1 2013 $380,200,000 +$30,400,000 +8.7% 31 Mar 2013 10-Q 06 May 2013 2013 Q1
Q4 2012 $384,700,000 +$34,900,000 +10% 31 Dec 2012 10-K 20 Feb 2015 2014 FY
Q3 2012 $349,800,000 $0 0% 30 Sep 2012 10-Q 07 Nov 2012 2012 Q3
Q2 2012 $349,800,000 -$100,000 -0.03% 30 Jun 2012 10-Q 07 Aug 2012 2012 Q2
Q1 2012 $349,800,000 -$100,000 -0.03% 31 Mar 2012 10-Q 09 May 2012 2012 Q1
Q4 2011 $349,800,000 +$34,600,000 +11% 31 Dec 2011 10-K 28 Feb 2014 2013 FY
Q3 2011 $349,800,000 +$34,600,000 +11% 30 Sep 2011 10-Q 08 Nov 2011 2011 Q3
Q2 2011 $349,900,000 +$34,700,000 +11% 30 Jun 2011 10-Q 08 Aug 2011 2011 Q2
Q1 2011 $349,900,000 31 Mar 2011 10-Q 09 May 2011 2011 Q1
Q4 2010 $315,200,000 31 Dec 2010 10-K 28 Feb 2013 2012 FY
Q3 2010 $315,200,000 30 Sep 2010 10-Q 08 Nov 2010 2010 Q3
Q2 2010 $315,200,000 30 Jun 2010 10-Q 06 Aug 2010 2010 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.